ClinicalThought


Share

Program Content

Activities

  • HER3 EGFRm NSCLC Care
    HER3-Targeted Therapies for EGFRm NSCLC: Emerging Therapies and Challenges in Treatment
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 09, 2024

    Expires: October 08, 2025

Faculty

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Professor, Department of Medicine
Cedars-Sinai Medical Center
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.